BeStock  
Stocks › Biotechnology › ANNX

Annexon ANNX

US equityMarket cap rank #3499Biotechnology
$3.10 −$0.31 (-9.09%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.41 +10.00%
Open$3.37
Prev close$3.41
Day range$3.07 – $3.37
Volume4.46M
Market cap$591.37M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$52.24M+8.4% YoY
Net profit-$51.22M+6.7% YoY
Diluted EPS-$0.25+32.4% YoY
Free cash flow-$48.68M+7.0% YoY
Operating cash flow-$48.68M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-48.6MDec '24$-54.4MMar '25$-49.2MJun '25$-54.9MSep '25$-48.3MDec '25$-44.1MMar '26$-55.3MJun '26$-51.2MSep '26

Diluted EPS by quarter

-0.33Dec '24-0.37Mar '25-0.34Jun '25-0.37Sep '25-0.28Dec '25-0.23Mar '26-0.28Jun '26-0.25Sep '26

Free cash flow by quarter

$-36.0MDec '24$-50.1MMar '25$-38.1MJun '25$-52.4MSep '25$-45.9MDec '25$-46.8MMar '26$-48.1MJun '26$-48.7MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-129.6%
Return on assets-82.2%
Return on invested capital-101.3%
Current ratio5.79
Liabilities / assets43.0%
Cash & investments$213.37M
Total debt$69.95M
Net cash (debt)$143.42M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $52.24M $57.23M $46.05M $216.41M $50.26M
Selling and Admin Expenses $10.87M $10.07M $9.61M $29.06M $4.95M
-General & Admin Expense $10.87M $10.07M $9.61M $29.06M $4.95M
Research & Development $41.37M $46.59M $35.79M $184.70M $42.66M
Operating Profit -$52.24M -$57.23M -$46.05M -$216.41M -$50.26M
Net Non-Operating Interest Income (Expense) $1.02M $1.88M $1.91M $9.72M $2.00M
Non-Operating Interest Income $1.85M $1.88M $1.91M $9.72M $2.00M
Non-Operating Interest Expense $833,000.00 – – – –
Pretax Profit -$51.22M -$55.35M -$44.14M -$206.69M -$48.26M
Net Profit -$51.22M -$55.35M -$44.14M -$206.69M -$48.26M
Profit from Continuing Operations -$51.22M -$55.35M -$44.14M -$206.69M -$48.26M
Net Income to Parent Company -$51.22M -$55.35M -$44.14M -$206.69M -$48.26M
Other Preferred Stock Dividends $0.00 $0.00 – – –
Net Income to Common Stockholders -$51.22M -$55.35M -$44.14M -$206.69M -$46.40M
Basic EPS -$0.25 -$0.28 -$0.23 -$1.34 -$0.28
Diluted EPS -$0.25 -$0.28 -$0.23 -$1.34 -$0.28
Depreciation & Amortization & Depletion – $564,000.00 $657,000.00 $2.65M –
-Depreciation & Amortization – $564,000.00 $657,000.00 $2.65M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $250.41M $246.07M $262.89M $277.57M $277.57M
Total Current Assets $217.90M $212.76M $228.27M $242.19M $242.19M
Cash and Cash Equivalents & Short-Term Investments $213.37M $209.24M $225.03M $238.35M $238.35M
-Cash and Cash Equivalents $102.39M $199.27M $175.21M $162.05M $162.05M
-Short Term Investments $110.99M $9.97M $49.82M $76.29M $76.29M
Other Current Assets $4.53M $3.51M $3.24M $1.24M $1.24M
Total Non-Current Assets $32.51M $33.31M $34.62M $35.38M $35.38M
Net PPE $23.05M $24.01M $24.87M $25.80M $25.80M
-Gross PPE $34.00M $34.43M $34.76M $35.15M $35.15M
-Accumulated Depreciation -$10.95M -$10.42M -$9.88M -$9.35M -$9.35M
Other Non-Current Assets $9.46M $9.30M $9.75M $9.58M $9.58M
Total Liabilities $107.61M $60.01M $58.36M $65.92M $65.92M
Total Current Liabilities $37.66M $38.48M $35.94M $42.63M $42.63M
Payables $15.91M $15.73M $17.53M $14.93M $14.93M
-Accounts Payable $15.91M $15.73M $17.53M $14.93M $14.93M
Current Accrued Expenses $12.15M $15.71M $12.69M $16.77M $16.77M
Short-Term Debt and Capital Lease Obligation $3.24M $3.13M $3.02M $2.91M $2.91M
-Current Capital Lease Obligation $3.24M $3.13M $3.02M $2.91M $2.91M
Other Current Liabilities $614,000.00 $193,000.00 $452,000.00 $509,000.00 $509,000.00
Total Non-Current Liabilities $69.95M $21.53M $22.42M $23.29M $23.29M
Long Term Debt and Capital Lease Obligation $69.95M $21.53M $22.42M $23.29M $23.29M
-Long Term Debt $49.34M – – – –
-Long Term Capital Lease Obligation $20.61M $21.53M $22.42M $23.29M $23.29M
Total Equity $142.80M $186.06M $204.53M $211.65M $211.65M
Stockholders' Equity $142.80M $186.06M $204.53M $211.65M $211.65M
Capital Stock $190,000.00 $175,000.00 $162,000.00 $149,000.00 $149,000.00
-Common Stock $190,000.00 $175,000.00 $162,000.00 $149,000.00 $149,000.00
Additional Paid-In Capital $1.21B $1.20B $1.17B $1.13B $1.13B
Retained Earnings -$1.07B -$1.02B -$961.53M -$917.39M -$917.39M
Gains/Losses Not Affecting Retained Earnings -$154,000.00 -$82,000.00 -$81,000.00 -$29,000.00 -$29,000.00
Prepaid Assets – – – $2.60M $2.60M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$48.68M -$48.01M -$46.80M -$186.36M -$45.93M
Net cash flow from continuing operations -$48.68M -$48.01M -$46.80M -$186.36M -$45.93M
Net Income from Continuing Operations -$51.22M -$55.35M -$44.14M -$206.69M -$48.26M
Depreciation & Depletion & Amortization $525,000.00 $540,000.00 $539,000.00 $2.17M $543,000.00
Other Non-Cash Items $583,000.00 $434,000.00 $418,000.00 $1.52M $402,000.00
Change in Working Capital -$3.09M $1.81M -$7.14M $4.23M -$1.50M
-Change in Prepaid Assets -$1.01M -$273,000.00 $605,000.00 $598,000.00 $255,000.00
-Change in Payables and Accrued Expense -$1.12M $2.87M -$7.25M $11.71M -$1.02M
-Change in Other Current Assets -$159,000.00 $0.00 $275,000.00 -$5.31M $1,000.00
-Change in Other Current Liabilities -$800,000.00 -$783,000.00 -$767,000.00 -$2.77M -$737,000.00
Net cash flow from investing -$100.50M $39.97M $27.06M $190.05M -$26.52M
Net Cash Flow from Continuing Investing Activities -$100.50M $39.97M $27.06M $190.05M -$26.52M
Net PPE Purchase and Sale $0.00 -$137,000.00 $0.00 -$137,000.00 $0.00
Net Investment Purchase and Sale -$100.50M $40.10M $27.06M $190.19M -$26.52M
Financing Cash Flow $52.30M $32.10M $32.90M $108.86M $95.08M
Net Cash Flow from Continuing Financing Activities $52.30M $32.10M $32.90M $108.86M $95.08M
Net Common Stock Issuance $2.62M $32.16M $33.60M $109.56M $95.37M
Proceeds from Stock Option Exercised $398,000.00 $1.05M $229,000.00 $915,000.00 $668,000.00
Net Other Financing Charges -$109,000.00 -$1.11M -$936,000.00 -$1.62M -$959,000.00
Ending Cash Balance $103.42M $200.30M $176.24M $163.08M $163.08M
Net Change in Cash -$96.88M $24.06M $13.16M $112.55M $22.63M
Beginning Cash Balance $200.30M $176.24M $163.08M $50.53M $140.45M
Effect of Exchange Rate Changes $0.00 $0.00 $1,000.00 $2,000.00 $0.00
Free Cash Flow -$48.68M -$48.14M -$46.80M -$186.49M -$45.93M

Discussion

No comments yet — be the first to weigh in on ANNX.

Sign in to join the discussion.

Scroll to Top